ClinicalTrialsFinder

Acute Promyelocytic Leukemia (APL) Clinical Trials in Stanford, California

1 recruitingStanford, California

Showing 1–1 of 1 trials

Recruiting
Phase 3

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Acute promyelocytic leukaemiaAcute Promyelocytic LeukemiaAcute Promyelocytic Leukemia With PML-RARA+2 more
Quetzal Therapeutics150 enrolled7 locationsNCT07504458